HCFA Coverage and Analysis Group
This article was originally published in The Gray Sheet
Hugh Hill, MD, will serve as interim acting director for the coverage group, effective immediately following the departure of Grant Bagley, MD, at the end of the month. Hill is a member of the Johns Hopkins University faculty, but currently is serving under a government exchange program as a medical officer in the Health Care Financing Administration's Center for Health Plans and Providers. While Hill was appointed in June by Administrator Nancy-Ann DeParle to chair HCFA's Physician Regulatory Review Issues Team, he has only worked full time at CHPP for the last several months. HCFA intends to mount a nation-wide search for a permanent replacement to Bagley, who recently signed on with the Washington, D.C. law firm Arnold & Porter (1"The Gray Sheet" Nov. 1, p. 4)
You may also be interested in...
A permanent replacement for Coverage and Analysis Group Director Grant Bagley, MD, likely will need to have a medical degree, the Health Care Financing Administration official observed after announcing his departure from the agency the week of Oct. 25.
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.